Helicobacter pylori (H. pylori) is a gram-negative anaerobic bacterium that colonizes nearly half of the global population. While most individuals remain asymptomatic, bacterial dysbiosis in the stomach has been linked to gastric neoplasia, chronic gastritis, and peptic ulcers. The clinical impacts of H. pylori overgrowth have also been linked to pathologies like obesity, diabetes, and non-alcoholic fatty liver disease. While the current pharmacological treatment for H. pylori includes multiple rounds of antibiotics and proton pump inhibitors, next-generation probiotics have been shown to increase H. pylori eradication rates while aiding conventional treatment and preserving gastrointestinal health. During this lecture, we will:
Learning Objective #1: Discuss an overview of the effects of the gut microbiota and H. pylori on the development of common pathologies.
Learning Objective #2: Summarize available research and clinical applications on the use of probiotics in the treatment of H. pylori.
Learning Objective #3: Assess common patterns in stool testing that link to H. pylori overgrowth.
Lacey Hall, MS, RD
Lacey Hall is a Registered Dietitian with a master’s degree in clinical nutrition. She is an expert in the intricacies of the human gut microbiome. Her background spans from use of medical nutrition therapy in medical intensive care to application of holistic medicine in the rainforests of Bali, Indonesia. Her original research on dietary supplement usage amongst hospitalized patients, catapulted her into a deeper desire to seek out integrative healthcare solutions. Lacey’s focus led her to a primary specialty in microbiome health and gut modulation. At Microbiome Labs, Lacey is the Head of Scientific Affairs. Here, she works with researchers and healthcare providers on gut microbiome testing, therapeutic interventions, and targeted strategies to support a balanced gut ecology. Her goal is to help advance the field of integrative medicine through evidenced-based recommendations and treatment protocols that help drive better patient outcomes.